
Opinion|Videos|October 14, 2024
Navigating PD-1/PD-L1 Agents: Influential Factors in Choosing the Right Therapy
Key Takeaways
- Route of administration impacts patient compliance and convenience, influencing the choice of PD-1/PD-L1 agents.
- Duration of therapy affects patients' quality of life and is a key consideration in treatment selection.
Panelists discuss how various factors, such as route of administration, duration of therapy, safety, efficacy, and cost, could influence the selection of different PD-1/PD-L1 agents once they receive approval, highlighting the importance of these considerations in optimizing patient care.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What factors could influence the choice between different PD-1/PD-L1 agents if they are eventually approved [ie, route of administration, duration of therapy, safety, efficacy, place of administration, drug preservation, biomarkers, cost, etc]?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
2
Study shows variability in response to long-term tamsulosin therapy
3
Managing Immune-Related Adverse Events With Durvalumab Plus BCG in NMIBC
4
Bringing POTOMAC Data Into Community Urology Practice for High-Risk NMIBC
5




